Trevena

FDA

FDA pulls breakthrough status from Trevena’s pain drug

Trevena has lost its breakthrough designation for pain treatment oliceridine, just a few months after the FDA rejected its application for the drug.

Phil Taylor Mar 8, 2019 10:19am

stop sign knerri61Pixabay

FDA rejects Trevena’s painkiller oliceridine

Nov 5, 2018 7:56am

opioid generic

Deconstructing an opioid receptor to create safer painkillers

Jan 5, 2018 3:03pm

pills medicine pharmacy

Mebias' mu opioids best morphine, Trevena med in preclinical studies

Oct 19, 2017 4:05pm

Axe and chopping block

Trevena sheds scientific staff, CSO to focus on lead pain drug

Oct 12, 2017 10:01am

News of note

Trevena CMO exit; AMO deal; Kala IPO; AliveCor-Mayo pact—News of Note

Jul 20, 2017 10:03am